Next Article in Journal
Comparison of Four SARS-CoV-2 Neutralization Assays
Next Article in Special Issue
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
Previous Article in Journal
Platforms Exploited for SARS-CoV-2 Vaccine Development
Previous Article in Special Issue
An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination
 
 
Review

Article Versions Notes

Action Date Notes Link
article html file updated 25 December 2025 01:04 CET Update https://www.mdpi.com/2076-393X/9/1/12/html
article html file updated 1 September 2025 17:05 CEST Update -
article html file updated 23 July 2022 07:37 CEST Update -
article html file updated 30 December 2020 11:16 CET Update -
article pdf uploaded. 30 December 2020 11:15 CET Updated version of record https://www.mdpi.com/2076-393X/9/1/12/pdf
article xml uploaded. 30 December 2020 11:15 CET Update https://www.mdpi.com/2076-393X/9/1/12/xml
article xml file uploaded 30 December 2020 11:15 CET Update -
article html file updated 26 December 2020 15:15 CET Original file -
article pdf uploaded. 26 December 2020 15:14 CET Version of Record https://www.mdpi.com/2076-393X/9/1/12/pdf-vor
article xml uploaded. 26 December 2020 15:14 CET Update -
article xml file uploaded 26 December 2020 15:14 CET Original file -
Back to TopTop